Pre-clinical models of genetically heterogeneous multiple myeloma reveal mechanisms of immune escape and predict clinical immunotherapy outcomes

被引：0

作者：

Larrayoz, Marta ^{[1
]}

Garcia-Barchino, Maria J. ^{[1
]}

Celay, Jon ^{[1
]}

Etxebeste, Amaia ^{[1
]}

Jimenez, Maddalen ^{[1
]}

Perez, Cristina ^{[1
]}

Ordonez, Raquel ^{[1
]}

Cobaleda, Cesar ^{[2
]}

Chesi, Marta ^{[3
]}

Bergsagel, Leif ^{[3
]}

Rodriguez-Otero, Paula ^{[4
]}

Takahashi, Satoru ^{[5
]}

Katz, Samuel G. ^{[6
]}

Walensky, Loren D. ^{[7
]}

Ruppert, Shannon M. ^{[8
]}

Lasater, Elisabeth A. ^{[8
]}

Amann, Maria ^{[9
]}

Lasarte, Juan J. ^{[1
]}

Kurilovich, Anna ^{[10
]}

Cerchietti, Leandro ^{[11
]}

Agirre, Xabier ^{[1
]}

San-Miguel, Jesus ^{[12
]}

Paiva, Bruno ^{[12
]}

Prosper, Felipe ^{[13
]}

Martinez-Climent, Jose A. ^{[1
]}

机构：

[1] Univ Navarra, Pamplona, Spain

[2] Univ Autonoma, Consejo Super Invest Cient, Ctr Biol Mol Severo Ochoa, Madrid, Spain

[3] Mayo Clin, Rochester, MN USA

[4] Clin Univ Navarra, CIMA, IDISNA, CIBERONC, Navarra, Spain

[5] Univ Tsukuba, Fac Med, Tsukuba, Ibaraki, Japan

[6] Yale Sch Med, New Haven, CT USA

[7] Harvard Med Sch, Dana Farber Canc Inst, Boston, MA 02115 USA

[8] Genentech Inc, San Francisco, CA USA

[9] Roche Innovat Ctr Zurich, Zurich, Switzerland

[10] Bostongene Corp, Waltham, MA USA

[11] Weill Cornell Med, New York, NY USA

[12] Clin Univ Navarra, Inst Invest Sanitaria Navarra IDISNA, Ctr Invest Med Aplicada CIMA, CCUN,CIBER ONC, Pamplona, Spain

[13] Clin Univ Navarra, Pamplona, Spain

来源：

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2022年 / 22卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

OAB-033

引用

页码：S19 / S20

页数：2

共 50 条

[21] An analysis of spine fusion outcomes in sheep pre-clinical models
Lindley, Emily M.
Barton, Cameron
Blount, Thomas
Burger, Evalina L.
Cain, Christopher M. J.
Seim, Howard B., III
Turner, A. Simon
Patel, Vikas V.
EUROPEAN SPINE JOURNAL, 2017, 26 (01) : 228 - 239
[22] Pre-clinical studies in support of the clinical development of Aplidin® (APL) for the treatment of Multiple Myeloma (MM).
Mitsiades, CS
Mitsiades, N
McMullan, CJ
Faircloth, G
Martin, JAL
Otero-Serrano, G
Anderson, KC
CLINICAL CANCER RESEARCH, 2003, 9 (16) : 6204S - 6204S
[23] Pre-clinical studies in support of the clinical development of aplidin® (APL) for the treatment of multiple myeloma (MM).
Mitsiades, CS
McMullan, CJ
Mitsiades, N
Faircloth, G
Lopez-Martin, JA
Otero-Serano, G
Anderson, KC
BLOOD, 2003, 102 (11) : 74A - 74A
[24] Activity of Orally Available CBP/p300 Degraders in Pre-Clinical Models of Multiple Myeloma
Tiwari, Praveen Kumar
Harrison, Drew A.
Ojeda, Samuel
Kawale, Ajinkya S.
Doda, Sai Reddy
Uannam, Raghu
Karakyriakou, Barbara
Koglin, Ann-Sophie
Rizvi, Sarah
Ott, Christopher J.
BLOOD, 2024, 144 : 2795 - 2795
[25] Naturally occurring cancers in pet dogs as pre-clinical models for cancer immunotherapy
Lidia Tarone
Giuseppina Barutello
Selina Iussich
Davide Giacobino
Elena Quaglino
Paolo Buracco
Federica Cavallo
Federica Riccardo
Cancer Immunology, Immunotherapy, 2019, 68 : 1839 - 1853
[26] Pre-clinical evaluation of bortezomib, doxorubicin, dexamethasone, and lenalidomide in multiple myeloma (MM)
Hari, M.
Hector-Word, Z.
Lebovic, D.
Soengas, M.
Jakubowiak, A.
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
[27] Immunotherapy in new pre-clinical models of HPV-associated oral cancers
Paolini, Francesca
Massa, Silvia
Manni, Isabella
Franconi, Rosella
Venuti, Aldo
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2013, 9 (03) : 534 - 543
[28] Naturally occurring cancers in pet dogs as pre-clinical models for cancer immunotherapy
Tarone, Lidia
Barutello, Giuseppina
Iussich, Selina
Giacobino, Davide
Quaglino, Elena
Buracco, Paolo
Cavallo, Federica
Riccardo, Federica
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2019, 68 (11) : 1839 - 1853
[29] An antisense platform for the pre-clinical development of novel LncRNA inhibitors in multiple myeloma
Morelli, Eugenio
Gulla, Annamaria
Liu, Na
Johnstone, Megan
Vinaixa, Delaney
Gramegna, Doriana
Wen, Kenneth
Tai, Yu-Tzu
Chauhan, Dharminder
Samur, Mehmet
Shammas, Masood
Fulciniti, Mariateresa
Gryaznov, Sergei
Anderson, Kenneth
Munshi, Nikhil
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S94 - S95
[30] Pre-Clinical and Clinical Immunomodulatory Effects of Pomalidomide or CC-92480 in Combination with Bortezomib in Multiple Myeloma
Bjorklund, Chad C.
Amatangelo, Michael
Chiu, Hsiling
Kang, Jian
Civardi, Tiziana
Katz, Jessica
Maciag, Paulo
Hagner, Patrick
Pourdehnad, Michael
Bahlis, Nizar J.
Richardson, Paul G.
Thakurta, Anjan
BLOOD, 2021, 138

← 1 2 3 4 5 →